Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
MNKD withdrew offer to DeSisto because of this news - Insulet Enters into Development Agreement with Eli Lilly for OmniPod Delivery of U200 Concentrated Insulin?
http://www.prnewswire.com/news-releases/insulet-enters-into-development-agreement-with-eli-lilly-for-omnipod-delivery-of-u200-concentrated-insulin-300201994.html
With this news, I just do not understand why the share price is still up with reasonably good volume? I mean shorts do not see this as a good time to cover, do they?
It could be suspended when pending for BO offer news release?
Can anyone here confirm:
Goldman Sachs upgrades MANNKIND CORPORATION from SELL to BUY.
BY Investars Analyst Actions - public
— 7:13 AM ET 01/07/2016
On January 6, 2016 Goldman Sachs upgraded MANNKIND CORPORATION ( MNKD
Loading...
Loading...
) from SELL to BUY.
So you mean to say Rosen is going to help the short sellers to drive the pps down.
If you recall the PR of new CEO appointment would be effective from Jan 05, 2016, rather than Jan 04, you should not be very surprised the intention for interim CEO to receive the official Notice from Sanofi.
I believe MNKD knew well in advance unofficially from SNY their intention to end the agreement and that is why they hire the new CEO to turn the new page after the notice was served before his report to work. Just my 2 cents
Realistically, it just takes time and money for MNKD to get this sales & marketing role done.
I do not expect much from the CC from the new CEO after market closed today.
Really feel helpless at current share price -- $0.77
Fierce competition amongst oral drugs for treating diabetes.
Did you see this "something" before?
No one can tell except SNY, which is responsible for marketing the drug.
Duane DeSisto on competing against corporate giants
"If you look at the kind of technology they had they really didn’t innovate all that much. What they did is they had a product, they had a need…When we came in if you look at a traditional insulin pump you couldn’t help but scratch your head and say with all the stuff that’s going on ‘there’s got to be a better way of doing this’ and so we went through this process. We created a products disposable, wears around your body, it’s completely discrete for diabetes patients and I think we have two real big advantages.
Obviously, they have more resources. We were completely and totally focused. In the time I’ve been Insulet now, 13 years, I’m on my now fifth CEO with [Medtronic’s] diabetes division so we got to be doing something right but it’s a weigh station at a lot of these big companies. As big as this space is I think the advantage all small companies have with an incredible amount of focus, you’re hell of a lot more efficient then.
We were able to create something that they really … they couldn’t even dream of it. I mean they spent a lot of time telling the world we were going to fail, they went out. We have five salespeople so they went out to the rest of the country, told people this was a size of a cantaloupe that you’re going to put on your body and it was all the typical stuff that a big company can do because they have resources. They just kept pounding away and pounding away and pounding away.
But we stayed on it. We were persistent about it. We created a product that we believe is by far best in the class and today we’re pushing $300 million in revenue."
http://www.massdevice.com/podcast-medtech-legends-and-leaders-state-medical-device-innovation/
Yes. Probably 100s of docs in every city of each states. Sounds realistic.
Merry Christmas to All of you here! Hope we all make good fortune entering into 2016!
Why did the share price shoot back up in a few seconds after the drop?
Why the effective day of the appointment is Jan 5, 2016 but not Dec 24, 2015 or January 2, 2016? Are we expecting something to happen in between Dec 24 to Jan 4, 2016 before the new CEO to show up?
European Patent Application
AN INHALABLE DRY POWDER FORMULATION COMPRISING GLP-1 FOR USE IN THE TREATMENT OF HYPERGLYCEMIA AND DIABETES
http://www.freepatentsonline.com/EP2954893A1.html
Types of Insulin for Diabetes Treatment
Many forms of insulin treat diabetes. They're grouped by how fast they start to work and how long their effects last.
The types of insulin include:
Rapid-acting
Short-acting
Intermediate-acting
Long-acting
Pre-mixed
What Type of Insulin Is Best for My Diabetes?
Your doctor will work with you to prescribe the type of insulin that's best for you and your diabetes. Making that choice will depend on many things, including:
-How you respond to insulin. (How long it takes the body to absorb it and how long it remains active varies from person to person.)
-Lifestyle choices. The type of food you eat, how much alcohol you drink, or how much exercise you get will all affect how your body uses insulin.
-Your willingness to give yourself multiple injections per day
-How often you check your blood sugar
-Your age
-Your goals for managing your blood sugar
Afrezza, a rapid-acting inhaled insulin, is FDA-approved for use before meals for both type 1 and type 2 diabetes. The drug peaks in your blood in about 15-20 minutes and it clears your body in 2-3 hours. It must be used along with long-acting insulin in people with type 1 diabetes.
The chart below lists the types of injectable insulin with details about onset (the length of time before insulin reaches the bloodstream and begins to lower blood sugar), peak (the time period when it best lowers blood sugar) and duration (how long insulin continues to work). These three things may vary. The final column offers some insight into the "coverage" provided by the different insulin types in relation to mealtime.
How Are Doses Scheduled?
Follow your doctor's guidelines on when to take your insulin. The time span between your shot and meals may vary depending on the type you use.
In general, though, you should coordinate your injection with a meal. From the chart on page 1, the "onset" column shows when the insulin will begin to work in your body. You want that to happen at the same time you're absorbing food. Good timing will help you avoid low blood sugar levels.
-Rapid acting insulins: About 15 minutes before mealtime
-Short-acting insulins: 30 to 60 minutes before a meal
-Intermediate-acting insulins: Up to 1 hour prior to a meal
-Pre-mixed insulins: Depending on the product, between 10 minutes or 30 to 45 minutes before mealtime
Exceptions to Insulin Dosing and Timing
Long-acting insulins aren’t tied to mealtimes. You’ll take detemir (Levemir) once or twice a day no matter when you eat. And you’ll take glargine (Lantus) once a day, always at the same time. But some people do have to pair a long-acting insulin with a shorter-acting type or another medication that does have to be taken at meal time.
Rapid-acting products can also be taken right after you eat, rather than 15 minutes before mealtime. You can take some of them at bedtime.
For more information about when to take insulin, read the "dosing and administration" section of the insulin product package insert that came with your insulin product, or talk with your doctor.
WebMD Medical Reference
View Article Sources
Reviewed by Michael Dansinger, MD on December 04, 2015
© 2015 WebMD, LLC. All rights reserved.
http://www.webmd.com/diabetes/guide/diabetes-types-insulin#1
What Type of Insulin Is Best for My Diabetes?
http://WWW.webmd.com/diabetes/guide/diabetes-types-insulin
PPS stays above $1.45 for a rebound in short term.
You are right. We just do not know if this is "Silence before Storm" or "Silence is Golden"!
I have not added further yet as capitulation is not set in.
Afrezza report on Orlando news station
Is this your own opinion or your doctor's that "Pills preferred over insulin as long as A-1 C under 7"?
"My AIC's are under 7.0 with using pills, so I can not even get the AFREZZA free samples. "
Doesn't it sounds like you are complaining not being able to get Afrezza at your doctor's office, despite it is available? Or it's your doctor's opinion that Afrezza should be given to those who are in real need?
You meant you got rejected trying out Afrezza or what? What was the reason?
"..I can not even get the AFREZZA free samples"
So are you a smoker or having problems with your lung?
Very informative website about Afrezza.
http://www.afrezzajustbreathe.com/
By looking at the monthly, weekly or daily charts, I must say this is not the right time to place my bet yet.
A PR of a new CEO appointment is only a stabilizer rather than a catalyst. It's worth 10% rise in pps at most, imo.
So were the questions you posted here yesterday, I guess.
Are you implying or encouraging me to sell?
Yes, drop clause in contract is very common in business practice unless someone has little knowledge of business world.
I bought more at $2.24 just now and had also bought as per below link:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=118445764
From LA Times
http://touch.latimes.com/#section/-1/article/p2p-85100692/
Edstrom, 65, was recruited by Mann in 2001 to become president of a company that would later be called MannKind.
He led the company through the regulatory process resulting in the June 2014 approval of Afrezza and was named chief executive in January after Mann stepped aside to become executive chairman.
In addition to chief executive, Edstrom served as president and a director of the company and has also stepped down from those roles, MannKind said.
In an interview with The Times this month, Edstrom said he was thinking of retiring soon.
Hakan shouldn't have taken up the CEO job in Jan this year if he have already had in mind a retirement. Or is this just an excuse?
Why MNKD does not disclose the reason of Hakan's departure or whether there has been any disagreement/ dispute? A bit strange to me.
Well, Hakan must have been fired by Alfred Mann for his lack of performance.
The content is nothing new but keeps repeating what has been told.
Good to hear that. Stay healthy, make money and take it easy.
MNKD hit 62% higher on Teva Exchange today with huge volume!
http://www.tase.co.il/Eng/General/Company/Pages/companyMainData.aspx?ShareID=01136639&CompanyID=001652&subDataType=0&
Am I glad to have bought more at $1.85 & $2.24. See you guys at $3.00.